German guideline for diagnosis and treatment of multiple sclerosis - a survey focusing neurologists in daily practise.


Journal

Multiple sclerosis and related disorders
ISSN: 2211-0356
Titre abrégé: Mult Scler Relat Disord
Pays: Netherlands
ID NLM: 101580247

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 05 04 2022
accepted: 21 04 2022
pubmed: 2 5 2022
medline: 29 6 2022
entrez: 1 5 2022
Statut: ppublish

Résumé

We performed a web-based survey among German-speaking neurologists to evaluate the acceptance of the 2021 German guideline in the diagnosis and treatment of multiple sclerosis. Based on 327 replies in total, the current survey largely reproduced the findings of an earlier, smaller survey on the prefinal consultation version of the guideline and confirmed high acceptance rates. Half of the participants were practising neurologists. Neurologists from MS centers with more than 500 patients per year (n=26) were more critical of the guideline. They reiterated some of the criticisms of the previous feedback, and, in particular, felt that safety aspects are overemphasized in the guideline, thereby superseding early aggressive therapy.

Identifiants

pubmed: 35490449
pii: S2211-0348(22)00340-6
doi: 10.1016/j.msard.2022.103828
pii:
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

103828

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

C Heesen (C)

Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: heesen@uke.de.

C Mokry (C)

Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

A Salmen (A)

Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.

H Hegen (H)

Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

M Mäurer (M)

Department of Neurology, Juliusspital, Würzburg, Germany.

C Warnke (C)

Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

K Gehring (K)

Neurocenter Klosterforst, Itzehoe, Germany.

A Berthele (A)

School of Medicine, Dept. of Neurology, Technical University Munich, Klinikum rechts der Isar, Munich, Germany.

U Meier (U)

Neurocenter, Grevenbroich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH